Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male
Investor Type
LinkedIn View on LinkedIn
Peter McWilliams is a CEO at Glycomine
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | ![]() PreciThera | ![]() Sanderling Ventures | ![]() Series A - PreciThera | obfuscated obfuscation | |
obfuscated obfuscation | Liphorus Pharmaceuticals | ![]() Sanderling Ventures | Series A - Liphorus Pharmaceuticals | obfuscated obfuscation | |
obfuscated obfuscation | ![]() Artielle ImmunoTherapeutics | ![]() Sanderling Ventures | ![]() Series A - Artielle ImmunoTherapeutics | obfuscated obfuscation |


Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
![]() Sanderling Ventures | |||
![]() Actimis Pharmaceuticals | |||
![]() Cylene Pharmaceuticals | |||
![]() Oxford Molecular Group | |||
![]() Genentech | |||
Booz Allen Hamilton |